Nycomed Reviewing Bids For U.S. Partners For Daxas
Bidding ended last week for potential U.S. partners for Nycomed’s new COPD drug, and the vetting process is under way.
Bidding ended last week for potential U.S. partners for Nycomed’s new COPD drug, and the vetting process is under way.